1. Brunell PA, Shehab ZM. Varicella-Zoster. In: Rose NR, Friedman H, Fahey JL. Manual of Clinical Laboratory Immunology. Washington DC: ASM, 1986: 502-503 [Google Scholar] 2. Giacchino R, Losurdo G, Castagnola E. Decline in mortality with varicella vaccination. N Engl J Med. 2005;352:1819. [PubMed] [Google Scholar] 3. Losurdo G, Bertoluzzo L, Canale F, Timitilli A, Bondi E, Castagnola E, Giacchino R. Varicella and its complications as cause of hospitalization. Infez Med. 2005;13:229–234. [PubMed] [Google Scholar] 4. Bertoluzzo L, Castagnola E, Losurdo G, Bondi E, Canale F, Giacchino R. The hospitalization because of varicella in a tertiary care pediatric hospital during 10 year study period. JPMH. 2005;46:169–172. [Google Scholar] 5. Center for Disease Control and Prevention (CDC) Varicella. Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book: Course Textbook - 13th ed 2015. [accessed 2016 Apr 4] Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/varicella.html. [Google Scholar] 6. Centers for Disease Control and Prevention (CDC) Varicella-related deaths among adults--United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46:409–412. [PubMed] [Google Scholar] 7. Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986;78:723–727. [PubMed] [Google Scholar] 8. Miller E. Marshall R. Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993;4:222–230. [Google Scholar] 9. Gabutti G. VZV infection: epidemiology and prevention. J Prev Med Hyg. 2007;48:65–71. [PubMed] [Google Scholar] 10. Smego RA, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol. 1991;78:1112–1116. [PubMed] [Google Scholar] 11. Baren JM, Henneman PL, Lewis RJ. Primary varicella in adults: pneumonia, pregnancy, and hospital admission. Ann Emerg Med. 1996;28:165–169. [PubMed] [Google Scholar] 12. Steele RW. Immunology of Varicella-Zoster Virus. In: Nahmias AJ, O'Reilly RJ. Immunology of Human Infection. Vol 9 Part II, New York: Springer, 1982: 73-88 In: Nahmias AJ, O'Reilly RJ, editors. [Google Scholar] 13. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635–645. [PubMed] [Google Scholar] 14. Schmidt NJ. Varicella-Zoster Virus. In: Manual of Clinical Microbiology. 4th ed. Lennette EH, Balows A, Hausler WJ, Shadomy HJ. Washington DC: American Society of Microbiology (ASM), 1985: 720-727 In: Manual of Clinical Microbiology., editor. [Google Scholar] 15. Takahashi M. Herpesviridae: varicella zoster virus. In EM Lennette, P Halonen, FA Murphy Laboratory diagnosis of infectious diseases: principles and practice. Viral, rickettsial, and chlamydial diseases. Vol 2. New York: Springer-Verlag, 1988: 261-275 [Google Scholar] 17. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis. 1994;169:91–94. [PubMed] [Google Scholar] 18. Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347:340–346. [PubMed] [Google Scholar] 19. Shrim A, Koren G, Yudin MH, Farine D. Management of varicella infection (chickenpox) in pregnancy. J Obstet Gynaecol Can. 2012;34:287–292. [PubMed] [Google Scholar] 20. Kido S, Ozaki T, Asada H, Higashi K, Kondo K, Hayakawa Y, Morishima T, Takahashi M, Yamanishi K. Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction. J Clin Microbiol. 1991;29:76–79. [PMC free article] [PubMed] [Google Scholar] 21. Grose C. Varicella infection during pregnancy. Herpes. 1999;6:33–37. [Google Scholar] 22. Goldblatt D. The immunology of chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36 Suppl 1:11–16. [PubMed] [Google Scholar] 23. Koropchak CM, Graham G, Palmer J, Winsberg M, Ting SF, Wallace M, Prober CG, Arvin AM. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis. 1991;163:1016–1022. [PubMed] [Google Scholar] 24. Tsolia M, Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr. 1990;116:184–189. [PubMed] [Google Scholar] 25. Chen JJ, Zhu Z, Gershon AA, Gershon MD. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell. 2004;119:915–926. [PubMed] [Google Scholar] 26. Tan MP, Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol. 2006;21:410–420. [PubMed] [Google Scholar] 27. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310–316. [PubMed] [Google Scholar] 28. Lungu O, Annunziato PW, Gershon A, Staugaitis SM, Josefson D, LaRussa P, Silverstein SJ. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA. 1995;92:10980–10984. [PMC free article] [PubMed] [Google Scholar] 29. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. 1999;130:922–932. [PubMed] [Google Scholar] 30. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev. 2010;23:202–217. [PMC free article] [PubMed] [Google Scholar] 31. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis. 1992;166 Suppl 1:S1–S6. [PubMed] [Google Scholar] 32. Gershon MD, Gershon AA. VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol. 2010;342:173–188. [PMC free article] [PubMed] [Google Scholar] 33. Straus SE, Ostrove JM, Inchauspé G, Felser JM, Freifeld A, Croen KD, Sawyer MH. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med. 1988;108:221–237. [PubMed] [Google Scholar] 34. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20. [PMC free article] [PubMed] [Google Scholar] 35. Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med. 1958;108:843–868. [PMC free article] [PubMed] [Google Scholar] 36. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342–348. [PubMed] [Google Scholar] 37. Dworkin RH. Post-herpetic neuralgia. Herpes. 2006;13 Suppl 1:21A–27A. [Google Scholar] 38. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992;166:1153–1156. [PubMed] [Google Scholar] 39. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26–33. [PubMed] [Google Scholar] 40. Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev. 2005;18:70–80. [PMC free article] [PubMed] [Google Scholar] 41. Volpi A. Varicella immunization and herpes zoster. Herpes. 2005;12:59. [PubMed] [Google Scholar] 42. Gershon AA. Varicella and Herpes zoster. Clinical diseases and complications. Herpes. 2006;13 Suppl 1:4A–8A. [Google Scholar] 43. Quinlivan M, Breuer J. Molecular studies of Varicella zoster virus. Rev Med Virol. 2006;16:225–250. [PubMed] [Google Scholar] 44. Nagler FP, Rake G. The Use of the Electron Microscope in Diagnosis of Variola, Vaccinia, and Varicella. J Bacteriol. 1948;55:45–51. [PMC free article] [PubMed] [Google Scholar] 45. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 1986;67(Pt 9):1759–1816. [PubMed] [Google Scholar] 46. Cohrs RJ, Hurley MP, Gilden DH. Array analysis of viral gene transcription during lytic infection of cells in tissue culture with Varicella-Zoster virus. J Virol. 2003;77:11718–11732. [PMC free article] [PubMed] [Google Scholar] 47. Davison AJ. Varicella-zoster virus. The Fourteenth Fleming lecture. J Gen Virol. 1991;72(Pt 3):475–486. [PubMed] [Google Scholar] 48. Cohen JI, Straus SS, Arvin A. Varicella-zoster virus, replication, pathogenesis and management. In: Knipe DM, Howley PM. Fields virology. Philadelphia: Lippincott-Raven Publishers, 2007: 2774-2818 In: Knipe DM, Howley PM, editors. [Google Scholar] 49. Mettenleiter TC. Budding events in herpesvirus morphogenesis. Virus Res. 2004;106:167–180. [PubMed] [Google Scholar] 50. Gershon AA. In: Crovari P, Principi N, editors. Varicella. In: Crovari P, Principi N. Le vaccinazioni. Pisa: Pacini Editore, 2000: 555-576. [Google Scholar] 51. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996;272:54–60. [PubMed] [Google Scholar] 52. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352:2266–2267. [PubMed] [Google Scholar] 53. Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Romero R. Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG. 2011;118:1155–1162. [PMC free article] [PubMed] [Google Scholar] 55. Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat Med. 2000;6:451–454. [PubMed] [Google Scholar] 56. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 1986;314:1542–1546. [PubMed] [Google Scholar] 57. Gershon AA. Chickenpox, Measles, and Mumps. In: Remington JS, Klein JO. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B Saunders Company, 2001: 683-732 In: Remington JS, Klein JO, editors. [Google Scholar] 58. Martin KA, Junker AK, Thomas EE, Van Allen MI, Friedman JM. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus. J Infect Dis. 1994;170:991–995. [PubMed] [Google Scholar] 59. Terada K, Kawano S, Shimada Y, Yagi Y, Kataoka N. Recurrent chickenpox after natural infection. Pediatr Infect Dis J. 1996;15:179–181. [PubMed] [Google Scholar] 60. Junker AK, Angus E, Thomas EE. Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr Infect Dis J. 1991;10:569–575. [PubMed] [Google Scholar] 61. Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis. 1984;149:137–142. [PubMed] [Google Scholar] 62. Gershon AA. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis. 1995;10:93–124. [PubMed] [Google Scholar] 63. Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, Mascola L, Wharton M. Second varicella infections: are they more common than previously thought? Pediatrics. 2002;109:1068–1073. [PubMed] [Google Scholar] 64. Arvin AM. Immune responses to varicella-zoster virus. Infect Dis Clin North Am. 1996;10:529–570. [PubMed] [Google Scholar] 65. Marin M, Nguyen HQ, Keen J, Jumaan AO, Mellen PM, Hayes EB, Gensheimer KF, Gunderman-King J, Seward JF. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003. Pediatrics. 2005;115:900–905. [PubMed] [Google Scholar] 66. Straus SE. Overview: the biology of varicella-zoster virus infection. Ann Neurol. 1994;35 Suppl:S4–S8. [PubMed] [Google Scholar] 67. Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26:728–743. [PMC free article] [PubMed] [Google Scholar] 68. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31:578–585. [PubMed] [Google Scholar] 69. Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus. J Infect Dis. 2004;190:72–82. [PubMed] [Google Scholar] 70. Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr. 2005;146:423–425. [PubMed] [Google Scholar] 71. van Loon AM, van der Logt JT, Heessen FW, Heeren MC, Zoll J. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster. Epidemiol Infect. 1992;108:165–174. [PMC free article] [PubMed] [Google Scholar] 72. Terada K, Niizuma T, Ogita S, Kataoka N. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine. Vaccine. 2002;20:3638–3643. [PubMed] [Google Scholar] 73. Bogger-Goren S, Bernstein JM, Gershon AA, Ogra PL. Mucosal cell-mediated immunity to varicella zoster virus: role in protection against disease. J Pediatr. 1984;105:195–199. [PubMed] [Google Scholar] 74. Arvin AM, Koropchak CM. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. J Clin Microbiol. 1980;12:367–374. [PMC free article] [PubMed] [Google Scholar] 75. Dubey L, Steinberg SP, LaRussa P, Oh P, Gershon AA. Western blot analysis of antibody to varicella-zoster virus. J Infect Dis. 1988;157:882–888. [PubMed] [Google Scholar] 76. Echevarría JM, Téllez A, Martínez-Martín P. Subclass distribution of the serum and intrathecal IgG antibody response in varicella-zoster virus infections. J Infect Dis. 1990;162:621–626. [PubMed] [Google Scholar] 77. Palumbo PE, Arvin AM, Koropchak CM, Wittek AE. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method. J Gen Virol. 1984;65(Pt 12):2141–2147. [PubMed] [Google Scholar] 78. Schmidt NJ, Gallo D. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses. J Med Virol. 1984;13:1–12. [PubMed] [Google Scholar] 79. Forghani B, Dupuis KW, Schmidt NJ. Epitopes functional in neutralization of varicella-zoster virus. J Clin Microbiol. 1990;28:2500–2506. [PMC free article] [PubMed] [Google Scholar] 80. Haumont M, Jurdan M, Kangro H, Jacquet A, Massaer M, Deleersnyder V, Garcia L, Bosseloir A, Bruck C, Bollen A, et al. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization. J Med Virol. 1997;53:63–68. [PubMed] [Google Scholar] 81. Vafai A, Wellish M, Wroblewska Z, Cisco M, Gilden D. Induction of antibody against in vitro translation products encoded by varicella-zoster virus glycoprotein genes. Virus Res. 1987;7:325–333. [PubMed] [Google Scholar] 82. Harper DR, Kangro HO, Heath RB. Serological responses in varicella and zoster assayed by immunoblotting. J Med Virol. 1988;25:387–398. [PubMed] [Google Scholar] 83. Cradock-Watson JE, Ridehalgh MK, Bourne MS. Specific immunoglobulin responses after varicella and herpes zoster. J Hyg (Lond) 1979;82:319–336. [PMC free article] [PubMed] [Google Scholar] 84. Kangro HO, Ward A, Argent S, Heath RB, Cradock-Watson JE, Ridehalgh MK. Detection of specific IgM in varicella and herpes zoster by antibody-capture radioimmunoassay. Epidemiol Infect. 1988;101:187–195. [PMC free article] [PubMed] [Google Scholar] 85. Sauerbrei A, Eichhorn U, Schacke M, Wutzler P. Laboratory diagnosis of herpes zoster. J Clin Virol. 1999;14:31–36. [PubMed] [Google Scholar] 86. Wittek AE, Arvin AM, Koropchak CM. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects. J Clin Microbiol. 1983;18:1146–1149. [PMC free article] [PubMed] [Google Scholar] 87. Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–1376. [PubMed] [Google Scholar] 88. Centers for Disease Control (CDC) Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 1999;48:1–5. [PubMed] [Google Scholar] 89. Enders G. Varicella-zoster virus infection in pregnancy. Prog Med Virol. 1984;29:166–196. [PubMed] [Google Scholar] 90. Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA, editors. Varicella-Zoster Virus Virology and Clinical Mangement. Cambridge: University Press; 2000. pp. 317–347. [Google Scholar] 91. Heininger U, Braun-Fahrländer C, Desgrandchamps D, Glaus J, Grize L, Wutzler P, Schaad UB. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J. 2001;20:775–778. [PubMed] [Google Scholar] 92. World Health Organization. Epidemiology of chickenpox. 1977-1990. Wkly Epidemiol Rec. 1992;67:118–119. [PubMed] [Google Scholar] 93. Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001;20:121–124. [PubMed] [Google Scholar] 94. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26. [PMC free article] [PubMed] [Google Scholar] 96. Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol. 2002;191:89–96. [PubMed] [Google Scholar] 97. Waaijenborg S, Hahné SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, de Melker HE, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208:10–16. [PMC free article] [PubMed] [Google Scholar] 98. de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A, Boot H. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24:3946–3952. [PubMed] [Google Scholar] 99. Gabutti G, Rota MC, Guido M, De Donno A, Bella A, Ciofi degli Atti ML, Crovari P. The epidemiology of Varicella Zoster Virus infection in Italy. BMC Public Health. 2008;8:372. [PMC free article] [PubMed] [Google Scholar] 100. Fleming DM, Schellevis FG, Falcao I, Alonso TV, Padilla ML. The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks. Eur J Epidemiol. 2001;17:1023–1027. [PubMed] [Google Scholar] 101. Díez-Domingo J, Aristegui J, Calbo F, Gonzalez-Hachero J, Moraga F, Peña Guitian J, Ruiz Contreras J, Torrellas A. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. Vaccine. 2003;21:3236–3239. [PubMed] [Google Scholar] 102. Ciofi Degli Atti ML, Salmaso S, Bella A, Arigliani R, Gangemi M, Chiamenti G, Brusoni G, Tozzi AE. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J. 2002;21:763–768. [PubMed] [Google Scholar] 103. Baldo V, Baldovin T, Russo F, Busana MC, Piovesan C, Bordignon G, Giliberti A, Trivello R. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis. 2009;9:150. [PMC free article] [PubMed] [Google Scholar] 104. García Cenoz M, Castilla J, Montes Y, Morán J, Salaberri A, Elía F, Floristán Y, Rodrígo I, Irisarri F, Arriazu M, et al. [Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006] An Sist Sanit Navar. 2008;31:71–80. [PubMed] [Google Scholar] 105. Valerio L, Escribá JM, Fernández-Vázquez J, Roca C, Milozzi J, Solsona L, Molina I. Biogeographical origin and varicella risk in the adult immigration population in Catalonia, Spain (2004-2006) Euro Surveill. 2009;14:pii: 19332. [PubMed] [Google Scholar] 106. Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, de Martino M. Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population. Infection. 2007;35:444–450. [PubMed] [Google Scholar] 107. Giaquinto C, Sturkenboom M, Mannino S, Arpinelli F, Nicolosi A, Cantarutti L. [Epidemiology and outcomes of varicella in Italy: results of a prospective study of children (0-14 years old) followed up by pediatricians (Pedianet study)] Ann Ig. 2002;14:21–27. [PubMed] [Google Scholar] 108. Socan M, Kraigher A, Pahor L. Epidemiology of varicella in Slovenia over a 20-year period (1979-98) Epidemiol Infect. 2001;126:279–283. [PMC free article] [PubMed] [Google Scholar] 109. Socan M, Blaško M. Surveillance of varicella and herpes zoster in Slovenia, 1996-2005. Euro Surveill. 2007;12:13–16. [Google Scholar] 110. Pérez-Farinós N, Ordobás M, García-Fernández C, García-Comas L, Cañellas S, Rodero I, Gutiérrez-Rodríguez A, García-Gutiérrez J, Ramírez R. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis. 2007;7:59. [PMC free article] [PubMed] [Google Scholar] 111. Nicolosi A, Sturkenboom M, Mannino S, Arpinelli F, Cantarutti L, Giaquinto C. The incidence of varicella: correction of a common error. Epidemiology. 2003;14:99–102. [PubMed] [Google Scholar] 113. Arama V, Rafila A, Streinu-Cercel A, Pistol A, Bacruban R, Sandu R, Pitigoi D, Negoita A. Varicella in Romania: epidemiological trends, 1986-2004. Euro Surveill. 2005;10:E050811.6. [PubMed] [Google Scholar] 114. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10:571–581. [PubMed] [Google Scholar] 115. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125:651–669. [PMC free article] [PubMed] [Google Scholar] 116. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis. 2000;182:383–390. [PubMed] [Google Scholar] 117. Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000;3:282–287. [PubMed] [Google Scholar] 118. Fairley CK, Miller E. Varicella-zoster virus epidemiology--a changing scene? J Infect Dis. 1996;174 Suppl 3:S314–S319. [PubMed] [Google Scholar] 119. Boëlle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002;129:599–606. [PMC free article] [PubMed] [Google Scholar] 120. Chant KG, Sullivan EA, Burgess MA, Ferson MJ, Forrest JM, Baird LM, Tudehope DI, Tilse M. Varicella-zoster virus infection in Australia. Aust N Z J Public Health. 1998;22:413–418. [PubMed] [Google Scholar] 121. Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ. 2001;323:1091–1093. [PMC free article] [PubMed] [Google Scholar] 122. Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, N-ur-Rehman B, Weil J, Bock H, Yazdani I. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000;31:646–649. [PubMed] [Google Scholar] 123. Garnett GP, Cox MJ, Bundy DA, Didier JM, St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect. 1993;110:361–372. [PMC free article] [PubMed] [Google Scholar] 124. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr. 2000;37:714–719. [PubMed] [Google Scholar] 125. Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S, Warachit B, Chup-Upprakarn S, Hutagalung Y, Weil J, Bock HL. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 2001;64:131–136. [PubMed] [Google Scholar] 126. Poveda JD, Babin M, Bonnici JF, du Pasquier P, Fleury HJ. [Serological study of the occurrence of Herpesviridae in French Guyana] Bull Soc Pathol Exot Filiales. 1986;79:207–212. [PubMed] [Google Scholar] 127. Sixl W, Schneeweiss WD, Withalm H, Schuhmann G, Rosegger H. Serological testing of human blood samples for infectious diseases in the Abeokuta and the Minna Hospitals/Nigeria. J Hyg Epidemiol Microbiol Immunol. 1987;31:490–492. [PubMed] [Google Scholar] 128. Sixl W, Sixl-Voigt B. Serological screenings of various infectious diseases on the Cape Verde Islands (West Africa) J Hyg Epidemiol Microbiol Immunol. 1987;31:469–471. [PubMed] [Google Scholar] 129. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health. 1998;3:886–890. [PubMed] [Google Scholar] 130. Venkitaraman AR, John TJ. The epidemiology of varicella in staff and students of a hospital in the tropics. Int J Epidemiol. 1984;13:502–505. [PubMed] [Google Scholar] 131. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics. 1976;58:692–696. [PubMed] [Google Scholar] 132. Dworkin RH. Racial differences in herpes zoster and age at onset of varicella. J Infect Dis. 1996;174:239–241. [PubMed] [Google Scholar] 133. Sinha DP. Chickenpox--a disease predominantly affecting adults in rural West Bengal, India. Int J Epidemiol. 1976;5:367–374. [PubMed] [Google Scholar] 134. Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T. Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. J Infect Dis. 1998;178 Suppl 1:S52–S54. [PubMed] [Google Scholar] 135. Poulsen A, Cabral F, Nielsen J, Roth A, Lisse IM, Vestergaard BF, Aaby P. Varicella zoster in Guinea-Bissau: intensity of exposure and severity of infection. Pediatr Infect Dis J. 2005;24:102–107. [PubMed] [Google Scholar] 136. Welgama U, Wickramasinghe C, Perera J. Varicella-zoster virus infection in the Infectious Diseases Hospital, Sri Lanka. Ceylon Med J. 2003;48:119–121. [PubMed] [Google Scholar] 137. Weller TH. Varicella: historical perspective and clinical overview. J Infect Dis. 1996;174 Suppl 3:S306–S309. [PubMed] [Google Scholar] 138. Leikin E, Figueroa R, Bertkau A, Lysikiewicz A, Visintainer P, Tejani N. Seronegativity to varicella-zoster virus in a tertiary care obstetric population. Obstet Gynecol. 1997;90:511–513. [PubMed] [Google Scholar] 139. Morgan-Capner P, Crowcroft NS. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy) Commun Dis Public Health. 2002;5:59–71. [PubMed] [Google Scholar] 140. Centers for Disease Control and Prevention (CDC) Decline in annual incidence of varicella--selected states, 1990-2001. MMWR Morb Mortal Wkly Rep. 2003;52:884–885. [PubMed] [Google Scholar] 141. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155:1605–1609. [PubMed] [Google Scholar] 142. Skull SA, Wang EE. Varicella vaccination--a critical review of the evidence. Arch Dis Child. 2001;85:83–90. [PMC free article] [PubMed] [Google Scholar] 143. Troughton JA, Crealey G, Crawford V, Coyle PV. Management of varicella contacts in pregnancy: VZIG or vaccination? J Clin Virol. 2009;46:345–348. [PubMed] [Google Scholar] 144. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med. 1985;313:1327–1330. [PubMed] [Google Scholar] 145. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343:1548–1551. [PubMed] [Google Scholar] 146. Sever J, White LR. Intrauterine viral infections. Annu Rev Med. 1968;19:471–486. [PubMed] [Google Scholar] 147. Sauerbrei A, Wutzler P. The congenital varicella syndrome. J Perinatol. 2000;20:548–554. [PubMed] [Google Scholar] 148. Mirlesse V, Lebon P. [Chickenpox during pregnancy] Arch Pediatr. 2003;10:1113–1118. [PubMed] [Google Scholar] 149. McKendrick MW, Lau J, Alston S, Bremner J. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention. J Infect. 2007;55:64–67. [PubMed] [Google Scholar] 150. Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP, Crowcroft NS, Brown DW, Breuer J. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect. 2007;135:1344–1353. [PMC free article] [PubMed] [Google Scholar] 151. Daley AJ, Thorpe S, Garland SM. Varicella and the pregnant woman: prevention and management. Aust N Z J Obstet Gynaecol. 2008;48:26–33. [PubMed] [Google Scholar] 152. Harger JH, Ernest JM, Thurnau GR, Moawad A, Thom E, Landon MB, Paul R, Miodovnik M, Dombrowski M, Sibai B, et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol. 2002;100:260–265. [PubMed] [Google Scholar] 153. Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol. 2001;21:545–549. [PubMed] [Google Scholar] 154. Landsberger EJ, Hager WD, Grossman JH. Successful management of varicella pneumonia complicating pregnancy. A report of three cases. J Reprod Med. 1986;31:311–314. [PubMed] [Google Scholar] 155. Harris RE, Rhoades ER. Varicella pneumonia complicating pregnancy. report of a case and review of literature. Obstet Gynecol. 1965;25:734–740. [PubMed] [Google Scholar] 156. Gardella C, Brown ZA. Managing varicella zoster infection in pregnancy. Cleve Clin J Med. 2007;74:290–296. [PubMed] [Google Scholar] 157. Schutte TJ, Rogers LC, Copas PR. Varicella pneumonia complicating pregnancy: a report of seven cases. Infect Dis Obstet Gynecol. 1996;4:338–346. [PMC free article] [PubMed] [Google Scholar] 158. Smith CK, Arvin AM. Varicella in the fetus and newborn. Semin Fetal Neonatal Med. 2009;14:209–217. [PubMed] [Google Scholar] 159. Sauerbrei A. Review of varicella-zoster virus infections in pregnant women and neonates. Health. 2010;2:143–152. [Google Scholar] 160. Broussard RC, Payne DK, George RB. Treatment with acyclovir of varicella pneumonia in pregnancy. Chest. 1991;99:1045–1047. [PubMed] [Google Scholar] 161. Greffe BS, Dooley SL, Deddish RB, Krasny HC. Transplacental passage of acyclovir. J Pediatr. 1986;108:1020–1021. [PubMed] [Google Scholar] 162. Chandra PC, Patel H, Schiavello HJ, Briggs SL. Successful pregnancy outcome after complicated varicella pneumonia. Obstet Gynecol. 1998;92:680–682. [PubMed] [Google Scholar] 163. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, Paul R, Miodovnik M, Dombrowski M, Sibai B, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185:422–427. [PubMed] [Google Scholar] 164. Mouly F, Mirlesse V, Méritet JF, Rozenberg F, Poissonier MH, Lebon P, Daffos F. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol. 1997;177:894–898. [PubMed] [Google Scholar] 165. Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol. 2007;196:95–102. [PubMed] [Google Scholar] 166. Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, Bar-Levy F, Jackson E, Donnenfeld A, Meschino W. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med. 1994;330:901–905. [PubMed] [Google Scholar] 167. Birthistle K, Carrington D. Fetal varicella syndrome--a reappraisal of the literature. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36 Suppl 1:25–29. [PubMed] [Google Scholar] 168. Alkalay AL, Pomerance JJ, Rimoin DL. Fetal varicella syndrome. J Pediatr. 1987;111:320–323. [PubMed] [Google Scholar] 169. Mandelbrot L. Fetal varicella - diagnosis, management, and outcome. Prenat Diagn. 2012;32:511–518. [PubMed] [Google Scholar] 170. Schulze A, Dietzsch HJ. The natural history of varicella embryopathy: a 25-year follow-up. J Pediatr. 2000;137:871–874. [PubMed] [Google Scholar] 171. Higa K, Dan K, Manabe H. Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol. 1987;69:214–222. [PubMed] [Google Scholar] 172. Grose C. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity. Mol Biol Med. 1989;6:453–462. [PubMed] [Google Scholar] 173. Sauerbrei A, Wutzler P. Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy. Curr Pediat Rev. 2005;1:205–215. [Google Scholar] 174. Prober CG, Gershon AA, Grose C, McCracken GH, Nelson JD. Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J. 1990;9:865–869. [PubMed] [Google Scholar] 175. Balducci J, Rodis JF, Rosengren S, Vintzileos AM, Spivey G, Vosseller C. Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol. 1992;79:5–6. [PubMed] [Google Scholar] 176. Jones KL, Johnson KA, Chambers CD. Offspring of women infected with varicella during pregnancy: a prospective study. Teratology. 1994;49:29–32. [PubMed] [Google Scholar] 177. Dufour P, de Bièvre P, Vinatier D, Tordjeman N, Da Lage B, Vanhove J, Monnier JC. Varicella and pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;66:119–123. [PubMed] [Google Scholar] 178. Figueroa-Damian R, Arredondo-Garcia JL. Perinatal outcome of pregnancies complicated with varicella infection during the first 20 weeks of gestation. Am J Perinatol. 1997;14:411–414. [PubMed] [Google Scholar] 179. Bai PV, John TJ. Congenital skin ulcers following varicella in late pregnancy. J Pediatr. 1979;94:65–67. [PubMed] [Google Scholar] 180. Kerkering KW. Abnormal cry and intracranial calcifications: clues to the diagnosis of fetal varicella-zoster syndrome. J Perinatol. 2001;21:131–135. [PubMed] [Google Scholar] 181. Deasy NP, Jarosz JM, Cox TC, Hughes E. Congenital varicella syndrome: cranial MRI in a long-term survivor. Neuroradiology. 1999;41:205–207. [PubMed] [Google Scholar] 182. Michie CA, Acolet D, Charlton R, Stevens JP, Happerfield LC, Bobrow LG, Kangro H, Gau G, Modi N. Varicella-zoster contracted in the second trimester of pregnancy. Pediatr Infect Dis J. 1992;11:1050–1053. [PubMed] [Google Scholar] 183. Lambert SR, Taylor D, Kriss A, Holzel H, Heard S. Ocular manifestations of the congenital varicella syndrome. Arch Ophthalmol. 1989;107:52–56. [PubMed] [Google Scholar] 184. Salzman MB, Sood SK. Congenital anomalies resulting from maternal varicella at 25 1/2 weeks of gestation. Pediatr Infect Dis J. 1992;11:504–505. [PubMed] [Google Scholar] 185. Ong CL, Daniel ML. Antenatal diagnosis of a porencephalic cyst in congenital varicella-zoster virus infection. Pediatr Radiol. 1998;28:94. [PubMed] [Google Scholar] 186. Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J Paediatr Child Health. 2000;36:108–113. [PubMed] [Google Scholar] 187. Koren G. Congenital varicella syndrome in the third trimester. Lancet. 2005;366:1591–1592. [PubMed] [Google Scholar] 189. Connan L, Ayoubi J, Icart J, Halasz A, Thene M, Berrebi A. Intra-uterine fetal death following maternal varicella infection. Eur J Obstet Gynecol Reprod Biol. 1996;68:205–207. [PubMed] [Google Scholar] 190. Siegel M. Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA. 1973;226:1521–1524. [PubMed] [Google Scholar] 191. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet. 1989;2:371–373. [PubMed] [Google Scholar] 192. Akisu M, Yalaz M, Aksu G, Arslanoglu S, Genel F, Kutukculer N, Kultursay N. Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children. Panminerva Med. 2003;45:155–156. [PubMed] [Google Scholar] 193. Heidl M. Varicella-Zoster-Virus-Infektion in der Schwangerschaft, beim Neugeborenen un jungen Säugling. Z Lin Med. 1985;40:245–250. [Google Scholar] 194. Yu HR, Chang JC, Chen RF, Chuang H, Hong KC, Wang L, Yang KD. Different antigens trigger different Th2/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol. 2003;74:952–958. [PubMed] [Google Scholar] 196. Meyers JD. Congenital varicella in term infants: risk reconsidered. J Infect Dis. 1974;129:215–217. [PubMed] [Google Scholar] 197. Gershon AA. Varicella in mother and infants: problems old and new. In: Krugman S, Gershon AA. Infections of the fetus and the newborn infant: progress in clinical and biological research. Vol 3. New York: Alan R Liss Inc, 1985: 79-85 In: Krugman S, Gershon AA, editors. [Google Scholar] 198. Cox SM, Cunningham FG, Luby J. Management of varicella pneumonia complicating pregnancy. Am J Perinatol. 1990;7:300–301. [PubMed] [Google Scholar] 199. Centers for Disease Control and Prevention (CDC) Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996;45:1–36. [PubMed] [Google Scholar] 200. Paulman PM, McLellan R. Varicella during pregnancy: the timing of effective treatment. J Am Board Fam Pract. 1990;3:121–123. [PubMed] [Google Scholar] 201. Zieger W, Friese K, Weigel M, Becker KP, Melchert F. Varicella infection at birth. Z Geburtshilfe Perinatol. 1994;198:134–137. [PubMed] [Google Scholar] 202. Rodríguez-Fanjul X, Noguera A, Vicente A, González-Enseñat MA, Jiménez R, Fortuny C. Herpes zoster in healthy infants and toddlers after perinatal exposure to varicella-zoster virus: a case series and review of the literature. Pediatr Infect Dis J. 2010;29:574–576. [PubMed] [Google Scholar] 203. Sauerbrei A, Wutzler P. Das fetale Varizellensyndrom. Monatsschr Kinderheilkd. 2003;151:209–213. [Google Scholar] 204. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2:1288–1290. [PubMed] [Google Scholar] 205. Takahashi M, Baba K, Horiuchi K, Kamiya H, Asano Y. A live varicella vaccine. Adv Exp Med Biol. 1990;278:49–58. [PubMed] [Google Scholar] 206. Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56:1–40. [PubMed] [Google Scholar] 207. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450–458. [PubMed] [Google Scholar] 208. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122:e744–e751. [PubMed] [Google Scholar] 209. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005. J Infect Dis. 2008;197 Suppl 2:S71–S75. [PubMed] [Google Scholar] 210. Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005;29:544–551. [PubMed] [Google Scholar] 211. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287:606–611. [PubMed] [Google Scholar] 212. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197 Suppl 2:S82–S89. [PubMed] [Google Scholar] 213. Dayan GH, Panero MS, Debbag R, Urquiza A, Molina M, Prieto S, Del Carmen Perego M, Scagliotti G, Galimberti D, Carroli G, et al. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol. 2004;42:5698–5704. [PMC free article] [PubMed] [Google Scholar] 214. Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness over time of varicella vaccine. JAMA. 2004;291:851–855. [PubMed] [Google Scholar] 215. Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect Control Hosp Epidemiol. 2001;22:279–283. [PubMed] [Google Scholar] 216. Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis. 2002;34:774–779. [PubMed] [Google Scholar] 217. Watson B. Varicella: a vaccine preventable disease? J Infect. 2002;44:220–225. [PubMed] [Google Scholar] 218. Vázquez M, Shapiro ED. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med. 2005;352:439–440. [PubMed] [Google Scholar] 219. White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics. 1991;87:604–610. [PubMed] [Google Scholar] 220. Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993;92:833–837. [PubMed] [Google Scholar] 221. Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA. The postmarketing safety profile of varicella vaccine. Vaccine. 2000;19:916–923. [PubMed] [Google Scholar] 222. Chaves SS, Zhang J, Civen R, Watson BM, Carbajal T, Perella D, Seward JF. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis. 2008;197 Suppl 2:S127–S131. [PubMed] [Google Scholar] 223. Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32:e305–e313. [PMC free article] [PubMed] [Google Scholar] 225. Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics. 1997;100:761–766. [PubMed] [Google Scholar] 226. Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994;94:524–526. [PubMed] [Google Scholar] 227. Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132–137. [PubMed] [Google Scholar] 228. Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination. Infection. 2006;34:222–226. [PubMed] [Google Scholar] 229. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Recomm Rep. 1997;46:1–42. [PubMed] [Google Scholar] 230. Gershon AA, LaRussa PS. Varicella vaccine. Pediatr Infect Dis J. 1998;17:248–249. [PubMed] [Google Scholar] 231. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309–318. [PubMed] [Google Scholar] 232. White CJ. Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am. 1996;10:595–608. [PubMed] [Google Scholar] 233. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis. 2004;189:1009–1012. [PubMed] [Google Scholar] 234. Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, Siqueira M, Poulsen A, Yaminishi K, Breuer J. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol. 2003;70 Suppl 1:S42–S47. [PubMed] [Google Scholar] 235. Peters GA, Tyler SD, Grose C, Severini A, Gray MJ, Upton C, Tipples GA. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol. 2006;80:9850–9860. [PMC free article] [PubMed] [Google Scholar] 236. Ferson MJ. Varicella vaccine in post-exposure prophylaxis. Commun Dis Intell. 2001;25:13–15. [PubMed] [Google Scholar] 237. Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, Levenson R. Postexposure effectiveness of varicella vaccine. Pediatrics. 2000;105:84–88. [PubMed] [Google Scholar] 238. Macartney K, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev. 2008;16:CD001833. [PubMed] [Google Scholar] 239. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update. Pediatrics. 2000;105:136–141. [PubMed] [Google Scholar] 241. Bohlke K, Galil K, Jackson LA, Schmid DS, Starkovich P, Loparev VN, Seward JF. Postpartum varicella vaccination: is the vaccine virus excreted in breast milk? Obstet Gynecol. 2003;102:970–977. [PubMed] [Google Scholar] 242. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–2284. [PubMed] [Google Scholar] 243. Koch-Institut R. Empfehlungen der Ständingen Impfkommission (STIKO) am Robert Koch-Institut/Stand. Epidemiol Bull. 2004;30:235–250. [Google Scholar] 245. Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36 Suppl 1:31–38. [PubMed] [Google Scholar] 248. Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol. 2005;33:89–95; discussion 96-98. [PubMed] [Google Scholar] 250. Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs. 1999;57:187–206. [PubMed] [Google Scholar] 251. Brunell PA. Varicella in pregnancy, the fetus, and the newborn: problems in management. J Infect Dis. 1992;166 Suppl 1:S42–S47. [PubMed] [Google Scholar] 252. Heuchan AM, Isaacs D. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases. Med J Aust. 2001;174:288–292. [PubMed] [Google Scholar] 253. Boxall EH, Maple PA, Rathod P, Smit E. Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox. Eur J Clin Microbiol Infect Dis. 2011;30:1193–1200. [PubMed] [Google Scholar] 254. Cohen A, Moschopoulos P, Stiehm RE, Koren G. Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. CMAJ. 2011;183:204–208. [PMC free article] [PubMed] [Google Scholar] 255. Gruslin A, Steben M, Halperin S, Money DM, Yudin MH. Immunization in pregnancy. J Obstet Gynaecol Can. 2009;31:1085–1101. [PubMed] [Google Scholar] 256. Nathwani D, Maclean A, Conway S, Carrington D. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36 Suppl 1:59–71. [PubMed] [Google Scholar] 257. Centers for Disease Control and Prevention (CDC) A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep. 2006;55:209–210. [PubMed] [Google Scholar] 258. Sharland M, Cant A, Davies EG, Elliman DA, Esposito S, Finn A, Gray J, Heath PT, Lyall H, et al. Chicken Pox-Varicella Zoster. In: Manual of Childhood Infections. The Blue Book. Oxford: Oxford University Press, 2011: 467-474 In: Manual of Childhood Infections., editor. [Google Scholar] 259. McIntosh D, Isaacs D. Varicella zoster virus infection in pregnancy. Arch Dis Child. 1993;68:1–2. [PMC free article] [PubMed] [Google Scholar] 260. Miller E. Varicella zoster virus infection in pregnancy. Arch Dis Child Fetal Neonatal Ed. 1994;70:F157–F158. [PMC free article] [PubMed] [Google Scholar] 261. Holland P, Isaacs D, Moxon ER. Fatal neonatal varicella infection. Lancet. 1986;2:1156. [PubMed] [Google Scholar] 262. King SM, Gorensek M, Ford-Jones EL, Read SE. Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin. Pediatr Infect Dis. 1986;5:588–589. [PubMed] [Google Scholar] 263. Lipton SV, Brunell PA. Management of varicella exposure in a neonatal intensive care unit. JAMA. 1989;261:1782–1784. [PubMed] [Google Scholar] 264. Deutsche Gesellschaft für Pädiatrische Infektiologie. Handbuch 2003: Infektionen im Kindesalter, Munchen: Futuramed, 2003: 732-739. [Google Scholar] 265. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child. 1993;69:639–642; discussion 642-643. [PMC free article] [PubMed] [Google Scholar] 266. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EC. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med. 1992;117:358–363. [PubMed] [Google Scholar] 267. Kempf W, Meylan P, Gerber S, Aebi C, Agosti R, Büchner S, Coradi B, Garweg J, Hirsch H, Kind C, et al. Swiss recommendations for the management of varicella zoster virus infections. Swiss Med Wkly. 2007;137:239–251. [PubMed] [Google Scholar] 268. Tunbridge AJ, Breuer J, Jeffery KJ. Chickenpox in adults - clinical management. J Infect. 2008;57:95–102. [PubMed] [Google Scholar] 269. Stone KM, Reiff-Eldridge R, White AD, Cordero JF, Brown Z, Alexander ER, Andrews EB. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol. 2004;70:201–207. [PubMed] [Google Scholar] 270. Mohsen AH, McKendrick M. Varicella pneumonia in adults. Eur Respir J. 2003;21:886–891. [PubMed] [Google Scholar] 271. Martínez Segura JM, Gutiérrez Oliver A, Maraví Poma E, Jiménez Urra I. [Severe chickenpox pneumonia] Rev Clin Esp. 2003;203:591–594. [PubMed] [Google Scholar] 272. Henderson GI, Hu ZQ, Johnson RF, Perez AB, Yang Y, Schenker S. Acyclovir transport by the human placenta. J Lab Clin Med. 1992;120:885–892. [PubMed] [Google Scholar] 273. Haddad J, Simeoni U, Paira M, Lokiec F, Messer J, Willard D. [Transplacental passage of acyclovir] Presse Med. 1987;16:1864. [PubMed] [Google Scholar] 274. Ratanajamit C, Vinther Skriver M, Jepsen P, Chongsuvivatwong V, Olsen J, Sørensen HT. Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study. Scand J Infect Dis. 2003;35:255–259. [PubMed] [Google Scholar] 275. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA. 2010;304:859–866. [PubMed] [Google Scholar] 276. Mills JL, Carter TC. Acyclovir exposure and birth defects: an important advance, but more are needed. JAMA. 2010;304:905–906. [PMC free article] [PubMed] [Google Scholar] 277. Acyclovir Pregnancy Registry and Valacyclovir Pregnancy Registry. Final study report. 1 June 1984 through 30 April 1999. Glaxo Welcome, 1999 [Google Scholar] 278. Carter PE, Duffy P, Lloyd DJ. Neonatal varicella infection. Lancet. 1986;2:1459–1460. [PubMed] [Google Scholar] 279. Schulze-Oechtering F, Roth B, Enders G, Grosser R. [Congenital varicella syndrome - is it infectious?] Z Geburtshilfe Neonatol. 2004;208:25–28. [PubMed] [Google Scholar] 280. Sauerbrei A, Pawlak J, Luger C, Wutzler P. Intracerebral varicella-zoster virus reactivation in congenital varicella syndrome. Dev Med Child Neurol. 2003;45:837–840. [PubMed] [Google Scholar] 281. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med. 1962;267:369–376. [PubMed] [Google Scholar] 282. Tyring SK. Natural history of varicella zoster virus. Semin Dermatol. 1992;11:211–217. [PubMed] [Google Scholar] 283. Mustonen K, Mustakangas P, Valanne L, Professor MH, Koskiniemi M. Congenital varicella-zoster virus infection after maternal subclinical infection: clinical and neuropathological findings. J Perinatol. 2001;21:141–146. [PubMed] [Google Scholar] 284. Seiler HE. A study of herpes zoster particularly in its relationship to chickenpox. J Hyg (Lond) 1949;47:253–262. [PMC free article] [PubMed] [Google Scholar] 285. Breuer J. Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission. J Infect Dis. 2008;197:635–637. [PubMed] [Google Scholar] 286. Josephson A, Gombert ME. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis. 1988;158:238–241. [PubMed] [Google Scholar] 287. Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis. 2008;197:646–653. [PubMed] [Google Scholar] 288. Suzuki K, Yoshikawa T, Tomitaka A, Suzuki K, Matsunaga K, Asano Y. Detection of varicella-zoster virus DNA in throat swabs of patients with herpes zoster and on air purifier filters. J Med Virol. 2002;66:567–570. [PubMed] [Google Scholar] 289. Yoshikawa T, Ihira M, Suzuki K, Suga S, Tomitaka A, Ueda H, Asano Y. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol. 2001;63:64–66. [PubMed] [Google Scholar] 290. Brazin SA, Simkovich JW, Johnson WT. Herpes zoster during pregnancy. Obstet Gynecol. 1979;53:175–181. [PubMed] [Google Scholar] 291. Eyal A, Friedman M, Peretz BA, Paldi E. Pregnancy complicated by herpes zoster. A report of two cases and literature review. J Reprod Med. 1983;28:600–603. [PubMed] [Google Scholar] 292. Webster MH, Smith CS. Congenital abnormalities and maternal herpes zoster. Br Med J. 1977;2:1193. [PMC free article] [PubMed] [Google Scholar] 293. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA. 2004;292:704–708. [PubMed] [Google Scholar] 294. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics. 1993;91:17–22. [PubMed] [Google Scholar] 295. Picone O, Vauloup-Fellous C, Senat MV, Frydman R, Grangeot-Keros L. Maternal varicella infection during pregnancy in a vaccinated patient. Prenat Diagn. 2008;28:971–972. [PubMed] [Google Scholar] 296. Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E. Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol. 2001;98:14–19. [PubMed] [Google Scholar] 297. Wilson E, Goss MA, Marin M, Shields KE, Seward JF, Rasmussen SA, Sharrar RG. Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis. 2008;197 Suppl 2:S178–S184. [PubMed] [Google Scholar] 298. Salzman MB, Sharrar RG, Steinberg S, LaRussa P. Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr. 1997;131:151–154. [PubMed] [Google Scholar] 299. Dolbear GL, Moffat J, Falkner C, Wojtowycz M. A pilot study: is attenuated varicella virus present in breast milk after postpartum immunization? Obstet Gynecol. 2003;101 Suppl 4:47S. [Google Scholar] 300. MacMahon E, Brown LJ, Bexley S, Snashall DC, Patel D. Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ. 2004;329:551–552. [PMC free article] [PubMed] [Google Scholar] 301. Ayres KL, Talukder Y, Breuer J. Humoral immunity following chickenpox is influenced by geography and ethnicity. J Infect. 2010;61:244–251. [PubMed] [Google Scholar] 302. Field N, Amirthalingam G, Waight P, Andrews N, Ladhani SN, van Hoek AJ, Maple PA, Brown KE, Miller E. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England. Vaccine. 2014;32:1213–1217. [PMC free article] [PubMed] [Google Scholar] 303. Watson B, Civen R, Reynolds M, Heath K, Perella D, Carbajal T, Mascola L, Jumaan A, Zimmerman L, James A, et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep. 2007;122:499–506. [PMC free article] [PubMed] [Google Scholar] 304. McGregor JA, Mark S, Crawford GP, Levin MJ. Varicella zoster antibody testing in the care of pregnant women exposed to varicella. Am J Obstet Gynecol. 1987;157:281–284. [PubMed] [Google Scholar] 305. Inocencion G, Loebstein R, Lalkin A, Geist R, Petric M, Koren G. Managing exposure to chickenpox during pregnancy. New program. Can Fam Physician. 1998;44:745–747. [PMC free article] [PubMed] [Google Scholar] 306. LaRussa P, Steinberg SP, Seeman MD, Gershon AA. Determination of immunity to varicella-zoster virus by means of an intradermal skin test. J Infect Dis. 1985;152:869–875. [PubMed] [Google Scholar] 307. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, McQuillan GM, Wharton M, Fehrs LJ, Cossen CK, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003;70 Suppl 1:S111–S118. [PubMed] [Google Scholar] 308. Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8:e81881. [PMC free article] [PubMed] [Google Scholar] 309. González-Escalada A, García-García L, Viguera-Ester P, Marín-García P, García J, Gil-de-Miguel A, Gil-Prieto R. Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain. Hum Vaccin Immunother. 2013;9:1918–1925. [PMC free article] [PubMed] [Google Scholar] 310. Guido M, Tinelli A, De Donno A, Quattrocchi M, Malvasi A, Campilongo F, Zizza A. Susceptibility to varicella-zoster among pregnant women in the province of Lecce, Italy. J Clin Virol. 2012;53:72–76. [PubMed] [Google Scholar] 311. van Rijckevorsel GG, Damen M, Sonder GJ, van der Loeff MF, van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis. 2012;12:140. [PMC free article] [PubMed] [Google Scholar] 312. van Rijckevorsel GG, Bovée LP, Damen M, Sonder GJ, Schim van der Loeff MF, van den Hoek A. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475. [PMC free article] [PubMed] [Google Scholar] 313. Urbiztondo L, Bayas JM, Broner S, Costa J, Esteve M, Campins M, Borrás E, Domínguez A. Varicella-zoster virus immunity among health care workers in Catalonia. Vaccine. 2014;32:5945–5948. [PubMed] [Google Scholar] 314. Socan M, Berginc N, Lajovic J. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health. 2010;10:360. [PMC free article] [PubMed] [Google Scholar] 315. Vilibic-Cavlek T, Ljubin-Sternak S, Kolaric B, Kaic B, Sviben M, Kos L, Mlinaric-Galinovic G. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing. Arch Gynecol Obstet. 2012;286:901–904. [PubMed] [Google Scholar] 316. Saadatian-Elahi M, Mekki Y, Del Signore C, Lina B, Derrough T, Caulin E, Thierry J, Vanhems P. Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol. 2007;22:405–409. [PubMed] [Google Scholar] 317. Sauerbrei A, Prager J, Bischoff A, Wutzler P. [Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;47:10–15. [PubMed] [Google Scholar] 318. Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 2005;112:50–56. [PubMed] [Google Scholar] 319. Tafuri S, Gallone MS, Cappelli MG, Gallone MF, Larocca AM, Germinario C. A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy) Vaccine. 2014;32:6544–6547. [PubMed] [Google Scholar] 320. Plans P, Costa J, Espuñes J, Plasència A, Salleras L. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG. 2007;114:1122–1127. [PubMed] [Google Scholar] 321. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25:7866–7872. [PubMed] [Google Scholar] 322. Bartoloni A, Bartalesi F, Roselli M, Mantella A, Dini F, Carballo ES, Barron VP, Paradisi F. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health. 2002;7:512–517. [PubMed] [Google Scholar] 323. Mamani M, Zamani M, Hashemi SH, Akhtari M, Niayesh, Seroepidemiology of varicella-virus among pregnant women in Hamedan, Iran. Afr J Microbiol Res. 2012;6:1829–1832. [Google Scholar] 324. Ghazi HO, Telmesani AM, Mahomed MF. TORCH agents in pregnant Saudi women. Med Princ Pract. 2002;11:180–182. [PubMed] [Google Scholar] 325. Pandolfi E, Chiaradia G, Moncada M, Rava L, Tozzi AE. Prevention of congenital rubella and congenital varicella in Europe. Euro Surveill. 2009;14:16–20. [PubMed] [Google Scholar] 326. Pinot de Moira A, Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill. 2005;10:43–45. [PubMed] [Google Scholar] 327. Koch-Institut R. Recommendations of the Standing Committee on Vaccinations: status. Epidemiol Bull. 2001;8:55–62. [Google Scholar] 328. Sauerbrei A, Schäfler A, Hofmann J, Schacke M, Gruhn B, Wutzler P. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clin Vaccine Immunol. 2012;19:1261–1268. [PMC free article] [PubMed] [Google Scholar] 329. Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol. 2001;8:871–879. [PMC free article] [PubMed] [Google Scholar] 330. Smith JG, Levin M, Vessey R, Chan IS, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, et al. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization. J Med Virol. 2003;70 Suppl 1:S38–S41. [PubMed] [Google Scholar] 331. Smith JG, Joseph HR, Green T, Field JA, Wooters M, Kaufhold RM, Antonello J, Caulfield MJ. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin Vaccine Immunol. 2007;14:527–537. [PMC free article] [PubMed] [Google Scholar] 332. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188:1336–1344. [PubMed] [Google Scholar] 333. van Besouw NM, Verjans GM, Zuijderwijk JM, Litjens NH, Osterhaus AD, Weimar W. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. J Med Virol. 2012;84:2018–2025. [PubMed] [Google Scholar] 334. Lafer MM, Weckx LY, de Moraes-Pinto MI, Garretson A, Steinberg SP, Gershon AA, LaRussa PS. Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus. Clin Vaccine Immunol. 2011;18:1194–1197. [PMC free article] [PubMed] [Google Scholar] 335. Baba K, Shiraki K, Kanesaki T, Yamanishi K, Ogra PL, Yabuuchi H, Takahashi M. Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections. J Clin Microbiol. 1987;25:2193–2196. [PMC free article] [PubMed] [Google Scholar] 336. Sato H, Yamamura Ji, Kageyama S, Kurokawa M, Shiraki K. Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine. Vaccine. 2003;22:15–20. [PubMed] [Google Scholar] 337. Takahashi M, Kamiya H, Asano Y, Shiraki K, Baba K, Otsuka T, Hirota T, Yamanishi K. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. Arch Virol Suppl. 2001;17:161–172. [PubMed] [Google Scholar] 338. Zerboni L, Nader S, Aoki K, Arvin AM. Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine. J Infect Dis. 1998;177:1701–1704. [PubMed] [Google Scholar] 339. Watson B, Boardman C, Laufer D, Piercy S, Tustin N, Olaleye D, Cnaan A, Starr SE. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis. 1995;20:316–319. [PubMed] [Google Scholar] 340. Watson B, Rothstein E, Bernstein H, Arbeter A, Arvin A, Chartrand S, Clements D, Kumar ML, Reisinger K, Blatter M. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis. 1995;172:217–219. [PubMed] [Google Scholar] 341. Nader S, Bergen R, Sharp M, Arvin AM. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis. 1995;171:13–17. [PubMed] [Google Scholar] 342. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics. 1977;59:3–7. [PubMed] [Google Scholar] 343. Asano Y, Nakayama H, Yazaki T, Ito S, Isomura S. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics. 1977;59:8–12. [PubMed] [Google Scholar] 344. Heath RB, Malpas JS. Experience with the live Oka-strain varicella vaccine in children with solid tumours. Postgrad Med J. 1985;61 Suppl 4:107–111. [PMC free article] [PubMed] [Google Scholar] 345. Gerna G, Achilli G, Chambers RW. Determination of neutralizing antibody and IgG antibody to varicella-zoster virus and of IgG antibody to membrane antigens by the immunoperoxidase technique. J Infect Dis. 1977;135:975–979. [PubMed] [Google Scholar] 346. Wreghitt TG, Tedder RS, Nagington J, Ferns RB. Antibody assays for varicella-zoster virus: comparison of competitive enzyme-linked immunosorbent assay (ELISA), competitive radioimmunoassay (RIA), complement fixation, and indirect immunofluorescence assays. J Med Virol. 1984;13:361–370. [PubMed] [Google Scholar] 347. Williams V, Gershon A, Brunell PA. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974;130:669–672. [PubMed] [Google Scholar] 348. Mendelson E, Aboudy Y, Smetana Z, Tepperberg M, Grossman Z. Laboratory assessment and diagnosis of congenital viral infections: Rubella, cytomegalovirus (CMV), varicella-zoster virus (VZV), herpes simplex virus (HSV), parvovirus B19 and human immunodeficiency virus (HIV) Reprod Toxicol. 2006;21:350–382. [PubMed] [Google Scholar] 349. Grist NR, Bell E J, Follett EAC, Urquhart GED. Diagnostic methods in clinical virology. 3rd ed. Oxford: Blackwell Scientific Publications, 1979: 95-115 [Google Scholar] 350. Gallo D, Schmidt NJ. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections. J Clin Microbiol. 1981;14:539–543. [PMC free article] [PubMed] [Google Scholar] 351. Forghani B, Schmidt NJ, Dennis J. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J Clin Microbiol. 1978;8:545–552. [PMC free article] [PubMed] [Google Scholar] 352. Gershon AA, Kalter ZG, Steinberg S, Kuhns WJ. Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med. 1976;151:762–765. [PubMed] [Google Scholar] 353. Gillani A, Spence L. Immune adherence hemagglutination test applied to the study of herpes simplex and varicella-zoster virus infections. J Clin Microbiol. 1978;7:114–117. [PMC free article] [PubMed] [Google Scholar] 354. Takahashi M. Current status and prospects of live varicella vaccine. Vaccine. 1992;10:1007–1014. [PubMed] [Google Scholar] 355. Wong CL, Castriciano S, Chernesky MA, Rawls WE. Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination. J Clin Microbiol. 1978;7:6–11. [PMC free article] [PubMed] [Google Scholar] 356. Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, Morton D, McLean AA, Scolnick EM. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA. 1985;254:2435–2439. [PubMed] [Google Scholar] 357. Chung A, Naylor DH. Detection of anti-varicella-zoster virus antibodies in blood donors by automated passive haemagglutination. Vox Sang. 1981;41:245–248. [PubMed] [Google Scholar] 358. Kino Y, Minamishima Y. Diagnosis of zoster and evaluation of varicella vaccine with a passive haemagglutination assay. Vaccine. 1993;11:1151–1153. [PubMed] [Google Scholar] 359. Kino Y, Minamishima Y. Passive hemagglutination assays for the detection of antibodies to herpes viruses. Microbiol Immunol. 1993;37:365–368. [PubMed] [Google Scholar] 360. Arvin AM, Kinney-Thomas E, Shriver K, Grose C, Koropchak CM, Scranton E, Wittek AE, Diaz PS. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol. 1986;137:1346–1351. [PubMed] [Google Scholar] 361. Campbell-Benzie A, Kangro HO, Heath RB. The development and evaluation of a solid-phase radioimmunoassay (RIA) procedure for the determination of susceptibility to varicella. J Virol Methods. 1981;2:149–158. [PubMed] [Google Scholar] 362. Harper DR, Grose C. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis. 1989;159:444–451. [PubMed] [Google Scholar] 363. Richman DD, Cleveland PH, Oxman MN, Zaia JA. A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus. J Infect Dis. 1981;143:693–699. [PubMed] [Google Scholar] 364. Krah DL. Assays for antibodies to varicella-zoster virus. Infect Dis Clin North Am. 1996;10:507–527. [PubMed] [Google Scholar] 365. Asano Y, Takahashi M. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics. 1977;60:810–814. [PubMed] [Google Scholar] 366. Asano Y, Albrecht P, Stagno S, Takahashi M. Potentiation of neutralization of Varicella-Zoster virus to antibody to immunoglobulin. J Infect Dis. 1982;146:524–529. [PubMed] [Google Scholar] 367. Asano Y, Albrecht P, Vujcic LK, Quinnan GV, Kawakami K, Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics. 1983;72:291–294. [PubMed] [Google Scholar] 368. Caunt AE, Shaw DG. Neutralization tests with varicella-zoster virus. J Hyg (Lond) 1969;67:343–352. [PMC free article] [PubMed] [Google Scholar] 369. Krah DL, Provost PJ, Ellis RW. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus. J Virol Methods. 1995;53:176–187. [PubMed] [Google Scholar] 370. Ozaki T, Nagayoshi S, Morishima T, Isomura S, Suzuki S, Asano Y, Takahashi M. Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children’s ward. Biken J. 1978;21:69–72. [PubMed] [Google Scholar] 371. Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH, White CJ, Miller WJ, Ellis RW. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine. 1991;9:111–116. [PubMed] [Google Scholar] 372. Schmidt NJ, Lennette EH. Neutralizing antibody responses to varicella-zoster virus. Infect Immun. 1975;12:606–613. [PMC free article] [PubMed] [Google Scholar] 373. Ueda K, Yamada I, Goto M, Nanri T, Fukuda H, Katsuta M, Otsuka T, Takahashi M. Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals. Biken J. 1977;20:117–123. [PubMed] [Google Scholar] 374. Asano Y, Takahashi M. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J. 1978;21:15–23. [PubMed] [Google Scholar] 375. Cremer NE, Cossen CK, Shell G, Diggs J, Gallo D, Schmidt NJ. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol. 1985;21:869–874. [PMC free article] [PubMed] [Google Scholar] 376. Grose C, Edmond BJ, Brunell PA. Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis. 1979;139:432–437. [PubMed] [Google Scholar] 377. Steinberg SP, Gershon AA. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J Clin Microbiol. 1991;29:1527–1529. [PMC free article] [PubMed] [Google Scholar] 378. Gershon AA, Larussa P, Steinberg S. Detection of antibodies to varicella-zoster virus using a latex agglutination assay. Clin Diagn Virol. 1994;2:271–277. [PubMed] [Google Scholar] 379. Landry ML, Ferguson D. Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol. 1993;31:3031–3033. [PMC free article] [PubMed] [Google Scholar] 380. Chris Maple PA, Gunn A, Sellwood J, Brown DW, Gray JJ. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals. J Virol Methods. 2009;155:143–149. [PubMed] [Google Scholar] 381. Ndumbe PM, Cradock-Watson J, Levinsky RJ. Natural and artificial immunity to varicella zoster virus. J Med Virol. 1988;25:171–178. [PubMed] [Google Scholar] 382. Schmidt NJ, Lennette EH, Woodie JD, Ho HH. Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections. J Lab Clin Med. 1965;66:403–412. [PubMed] [Google Scholar] 383. Vafai A. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein. Vaccine. 1994;12:1265–1269. [PubMed] [Google Scholar] 384. Sauerbrei A, Färber I, Brandstädt A, Schacke M, Wutzler P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Methods. 2004;119:25–30. [PubMed] [Google Scholar] 385. Mazur MH, Whitley RJ, Dolin R. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979;139:1341–1345. [PubMed] [Google Scholar] 386. Paryani SG, Arvin AM, Koropchak CM, Dobkin MB, Wittek AE, Amylon MD, Budinger MD. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. J Pediatr. 1984;105:200–205. [PubMed] [Google Scholar] 387. Zaia JA, Oxman MN. Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis. 1977;136:519–530. [PubMed] [Google Scholar] 388. Park R, Hwang JY, Lee KI, Namkoong S, Choi SK, Park S, Park H, Park J. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibody-to-membrane-antigen (FAMA) test. J Microbiol Biotechnol. 2015;25:268–273. [PubMed] [Google Scholar] 389. Grose C, Edwards DP, Friedrichs WE, Weigle KA, McGuire WL. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun. 1983;40:381–388. [PMC free article] [PubMed] [Google Scholar] 390. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis. 1988;158:132–137. [PubMed] [Google Scholar] 391. Iltis JP, Castellano GA, Gerber P, Le C, Vujcic LK, Quinnan GV. Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus. J Clin Microbiol. 1982;16:878–884. [PMC free article] [PubMed] [Google Scholar] 392. Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008;197:944–949. [PMC free article] [PubMed] [Google Scholar] 393. McDonald SL, Maple PA, Andrews N, Brown KE, Ayres KL, Scott FT, Al Bassam M, Gershon AA, Steinberg SP, Breuer J. Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers. J Virol Methods. 2011;172:60–65. [PMC free article] [PubMed] [Google Scholar] 394. Maple PA, Gray J, Breuer J, Kafatos G, Parker S, Brown D. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol. 2006;13:214–218. [PMC free article] [PubMed] [Google Scholar] 395. Craig WY, Poulin SE, Dorsett PH, Ledue TB, Ritchie RF. Application of checkerboard immunoblotting (CBIB) to the detection of anti-viral IgG in human serum. J Clin Lab Anal. 1993;7:203–208. [PubMed] [Google Scholar] 396. Kim YH, Hwang JY, Shim HM, Lee E, Park S, Park H. Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella. Yonsei Med J. 2014;55:459–466. [PMC free article] [PubMed] [Google Scholar] 397. Maple PA, Breuer J, Quinlivan M, Kafatos G, Brown KE. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers. J Clin Virol. 2012;53:201–207. [PubMed] [Google Scholar] 398. Gershon AA, Frey HM, Steinberg SP, Seeman MD, Bidwell D, Voller A. Determination of immunity to varicella using an enzyme-linked-immunosorbent-assay. Arch Virol. 1981;70:169–172. [PubMed] [Google Scholar] 399. Larussa P, Steinberg S, Waithe E, Hanna B, Holzman R. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. J Clin Microbiol. 1987;25:2059–2062. [PMC free article] [PubMed] [Google Scholar] 400. Weinberg A, Hayward AR, Masters HB, Ogu IA, Levin MJ. Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J Clin Microbiol. 1996;34:445–446. [PMC free article] [PubMed] [Google Scholar] 401. Doern GV, Robbie L, St Amand R. Comparison of the Vidas and Bio-Whittaker enzyme immunoassays for detecting IgG reactive with varicella-zoster virus and mumps virus. Diagn Microbiol Infect Dis. 1997;28:31–34. [PubMed] [Google Scholar] 402. Rolando L, Schneider WJ, Steinberg S, Low S, Stiles J, Gomez L, Gershon AA, Brown AE. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days. Infect Control Hosp Epidemiol. 2010;31:972–974. [PMC free article] [PubMed] [Google Scholar] 403. de Ory F, Echevarría JM, Kafatos G, Anastassopoulou C, Andrews N, Backhouse J, Berbers G, Bruckova B, Cohen DI, de Melker H, et al. European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus. J Clin Virol. 2006;36:111–118. [PubMed] [Google Scholar] 404. Keller PM, Lonergan K, Neff BJ, Morton DA, Ellis RW. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies. J Virol Methods. 1986;14:177–188. [PubMed] [Google Scholar] 405. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol. 1990;32:189–193. [PubMed] [Google Scholar] 406. Watson B, Gupta R, Randall T, Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis. 1994;169:197–199. [PubMed] [Google Scholar] 407. White CJ, Kuter BJ, Ngai A, Hildebrand CS, Isganitis KL, Patterson CM, Capra A, Miller WJ, Krah DL, Provost PJ, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J. 1992;11:19–23. [PubMed] [Google Scholar] 409. Hammond O, Wang Y, Green T, Antonello J, Kuhn R, Motley C, Stump P, Rich B, Chirmule N, Marchese RD. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. J Med Virol. 2006;78:1679–1687. [PubMed] [Google Scholar] 410. Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, Schmid DS, Seward JF. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis. 2008;197 Suppl 2:S132–S138. [PubMed] [Google Scholar] 411. Krah DL, Cho I, Schofield T, Ellis RW. Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults. Vaccine. 1997;15:61–64. [PubMed] [Google Scholar] 412. Sauerbrei A, Wutzler P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol. 2006;44:3094–3097. [PMC free article] [PubMed] [Google Scholar] 413. Li S, Chan IS, Matthews H, Heyse JF, Chan CY, Kuter BJ, Kaplan KM, Vessey SJ, Sadoff JC. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J. 2002;21:337–342. [PubMed] [Google Scholar] 414. Maple PA, Rathod P, Smit E, Gray J, Brown D, Boxall EH. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. J Clin Virol. 2009;44:9–14. [PubMed] [Google Scholar] 415. Binnicker MJ, Jespersen DJ, Rollins LO. Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay. Clin Vaccine Immunol. 2011;18:1524–1526. [PMC free article] [PubMed] [Google Scholar] 416. Dhiman N, Jespersen DJ, Rollins LO, Harring JA, Beito EM, Binnicker MJ. Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay. Diagn Microbiol Infect Dis. 2010;67:346–349. [PubMed] [Google Scholar] 417. Smits GP, van Gageldonk PG, Schouls LM, van der Klis FR, Berbers GA. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol. 2012;19:396–400. [PMC free article] [PubMed] [Google Scholar] 418. Jääskeläinen AJ, Moilanen K, Bühler S, Lappalainen M, Vapalahti O, Vaheri A, Piiparinen H. Serological microarray for detection of HSV-1, HSV-2, VZV, and CMV antibodies. J Virol Methods. 2009;160:167–171. [PubMed] [Google Scholar] 419. Ardizzoni A, Capuccini B, Baschieri MC, Orsi CF, Rumpianesi F, Peppoloni S, Cermelli C, Meacci M, Crisanti A, Steensgaard P, et al. A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections. Eur J Clin Microbiol Infect Dis. 2009;28:1067–1075. [PubMed] [Google Scholar] 420. Cohen PR. Tests for detecting herpes simplex virus and varicella-zoster virus infections. Dermatol Clin. 1994;12:51–68. [PubMed] [Google Scholar] 421. Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL. Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA. 1992;268:2541–2544. [PubMed] [Google Scholar] 422. Ozcan A, Senol M, Saglam H, Seyhan M, Durmaz R, Aktas E, Ozerol IH. Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol. 2007;46:1177–1179. [PubMed] [Google Scholar] 423. Schirm J, Meulenberg JJ, Pastoor GW, van Voorst Vader PC, Schröder FP. Rapid detection of varicella-zoster virus in clinical specimens using monoclonal antibodies on shell vials and smears. J Med Virol. 1989;28:1–6. [PubMed] [Google Scholar] 424. Folkers E, Vreeswijk J, Oranje AP, Duivenvoorden JN. Rapid diagnosis in varicella and herpes zoster: re-evaluation of direct smear (Tzanck test) and electron microscopy including colloidal gold immuno-electron microscopy in comparison with virus isolation. Br J Dermatol. 1989;121:287–296. [PubMed] [Google Scholar] 425. Sadick NS, Swenson PD, Kaufman RL, Kaplan MH. Comparison of detection of varicella-zoster virus by the Tzanck smear, direct immunofluorescence with a monoclonal antibody, and virus isolation. J Am Acad Dermatol. 1987;17:64–69. [PubMed] [Google Scholar] 426. Solomon AR, Rasmussen JE, Weiss JS. A comparison of the Tzanck smear and viral isolation in varicella and herpes zoster. Arch Dermatol. 1986;122:282–285. [PubMed] [Google Scholar] 427. Sullivan M, Sams R, Jamieson B, Holt J. Clinical inquiries. What is the best test to detect herpes in skin lesions? J Fam Pract. 2006;55:346, 348. [PubMed] [Google Scholar] 428. Frisch S, Guo AM. Diagnostic methods and management strategies of herpes simplex and herpes zoster infections. Clin Geriatr Med. 2013;29:501–526. [PubMed] [Google Scholar] 429. Fan F, Day S, Lu X, Tang YW. Laboratory diagnosis of HSV and varicella zoster virus infections. Future Virol. 2014;9:721–731. [Google Scholar] 430. Vreeswijk J, Folkers E, Wagenaar F, Kapsenberg JG. The use of colloidal gold immunoelectron microscopy to diagnose varicella-zoster virus (VZV) infections by rapid discrimination between VZV, HSV-1 and HSV-2. J Virol Methods. 1988;22:255–271. [PubMed] [Google Scholar] 431. Williams MG, Almeida JD, Howatson AF. Electron microscope studies on viral skin lesions. A simple and rapid method of identifying virus particles. Arch Dermatol. 1962;86:290–297. [PubMed] [Google Scholar] 432. Folkers E, Vreeswijk J, Oranje AP, Wagenaar F, Duivenvoorden JN. Improved detection of HSV by electron microscopy in clinical specimens using ultracentrifugation and colloidal gold immunoelectron microscopy: comparison with viral culture and cytodiagnosis. J Virol Methods. 1991;34:273–289. [PMC free article] [PubMed] [Google Scholar] 433. Drew WL, Mintz L. Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence. Am J Clin Pathol. 1980;73:699–701. [PubMed] [Google Scholar] 434. Coffin SE, Hodinka RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microbiol. 1995;33:2792–2795. [PMC free article] [PubMed] [Google Scholar] 435. Sefcovicová L. Varicella-zoster virus cultivation in cell cultures of non-primate origin. Acta Virol. 1971;15:171–173. [PubMed] [Google Scholar] 436. Brinker JP, Doern GV. Comparison of MRC-5 and A-549 cells in conventional culture tubes and shell vial assays for the detection of varicella-zoster virus. Diagn Microbiol Infect Dis. 1993;17:75–77. [PubMed] [Google Scholar] 437. Huang YT, Hite S, Duane V, Yan H. CV-1 and MRC-5 mixed cells for simultaneous detection of herpes simplex viruses and varicella zoster virus in skin lesions. J Clin Virol. 2002;24:37–43. [PubMed] [Google Scholar] 438. Gleaves CA, Lee CF, Bustamante CI, Meyers JD. Use of murine monoclonal antibodies for laboratory diagnosis of varicella-zoster virus infection. J Clin Microbiol. 1988;26:1623–1625. [PMC free article] [PubMed] [Google Scholar] 439. West PG, Aldrich B, Hartwig R, Haller GJ. Increased detection rate for varicella-zoster virus with combination of two techniques. J Clin Microbiol. 1988;26:2680–2681. [PMC free article] [PubMed] [Google Scholar] 440. Leland DS, Ginocchio CC. Role of cell culture for virus detection in the age of technology. Clin Microbiol Rev. 2007;20:49–78. [PMC free article] [PubMed] [Google Scholar] 441. Kodama E, Mori S, Shigeta S. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2’-deoxyuridine and 5-bromo-2’-deoxyuridine. Antiviral Res. 1995;27:165–170. [PubMed] [Google Scholar] 442. Andrei G, Snoeck R, Reymen D, Liesnard C, Goubau P, Desmyter J, De Clercq E. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis. 1995;14:318–329. [PubMed] [Google Scholar] 443. Dahl H, Marcoccia J, Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol. 1997;35:347–349. [PMC free article] [PubMed] [Google Scholar] 444. Olding-Stenkvist E, Grandien M. Early diagnosis of virus-caused vesicular rashes by immunofluorescence on skin biopsies. I. Varicella, zoster and herpes simplex. Scand J Infect Dis. 1976;8:27–35. [PubMed] [Google Scholar] 445. Schmidt NJ, Gallo D, Devlin V, Woodie JD, Emmons RW. Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens. J Clin Microbiol. 1980;12:651–655. [PMC free article] [PubMed] [Google Scholar] 446. Pérez JL, García A, Niubò J, Salvà J, Podzamczer D, Martín R. Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens. J Clin Microbiol. 1994;32:1610–1613. [PMC free article] [PubMed] [Google Scholar] 447. Rawlinson WD, Dwyer DE, Gibbons VL, Cunningham AL. Rapid diagnosis of varicella-zoster virus infection with a monoclonal antibody based direct immunofluorescence technique. J Virol Methods. 1989;23:13–18. [PubMed] [Google Scholar] 448. Zirn JR, Tompkins SD, Huie C, Shea CR. Rapid detection and distinction of cutaneous herpesvirus infections by direct immunofluorescence. J Am Acad Dermatol. 1995;33:724–728. [PubMed] [Google Scholar] 449. Espy MJ, Teo R, Ross TK, Svien KA, Wold AD, Uhl JR, Smith TF. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38:3187–3189. [PMC free article] [PubMed] [Google Scholar] 450. Stránská R, Schuurman R, de Vos M, van Loon AM. Routine use of a highly automated and internally controlled real-time PCR assay for the diagnosis of herpes simplex and varicella-zoster virus infections. J Clin Virol. 2004;30:39–44. [PubMed] [Google Scholar] 451. Campsall PA, Au NH, Prendiville JS, Speert DP, Tan R, Thomas EE. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol. 2004;42:1409–1413. [PMC free article] [PubMed] [Google Scholar] 452. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992;66:1016–1020. [PMC free article] [PubMed] [Google Scholar] 453. Engelmann I, Petzold DR, Kosinska A, Hepkema BG, Schulz TF, Heim A. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. J Med Virol. 2008;80:467–477. [PubMed] [Google Scholar] 454. Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol. 2000;38:3156–3160. [PMC free article] [PubMed] [Google Scholar] 455. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol. 2000;38:4315–4319. [PMC free article] [PubMed] [Google Scholar] 456. Parker SP, Quinlivan M, Taha Y, Breuer J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol. 2006;44:3911–3914. [PMC free article] [PubMed] [Google Scholar] 457. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JD, Wengenack NL, Rosenblatt JE, Cockerill FR, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19:165–256. [PMC free article] [PubMed] [Google Scholar] 458. Cobo F. Application of molecular diagnostic techniques for viral testing. Open Virol J. 2012;6:104–114. [PMC free article] [PubMed] [Google Scholar] 459. Ihira M, Higashimoto Y, Kawamura Y, Sugata K, Ohashi M, Asano Y, Yoshikawa T. Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains. J Virol Methods. 2013;193:308–313. [PubMed] [Google Scholar] 460. Tang YW, Allawi HT, DeLeon-Carnes M, Li H, Day SP, Schmid D. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method. J Clin Virol. 2007;40:129–134. [PubMed] [Google Scholar] 461. Thiele S, Borschewski A, Küchler J, Bieberbach M, Voigt S, Ehlers B. Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions. Clin Vaccine Immunol. 2011;18:1058–1066. [PMC free article] [PubMed] [Google Scholar] 462. Toi CS, Dwyer DE. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms. J Clin Virol. 2008;43:18–24. [PubMed] [Google Scholar] 463. Sauerbrei A, Uebe B, Wutzler P. Molecular diagnosis of zoster post varicella vaccination. J Clin Virol. 2003;27:190–199. [PubMed] [Google Scholar] 464. Fan F, Stiles J, Mikhlina A, Lu X, Babady NE, Tang YW. Clinical validation of the Lyra direct HSV 1+2/VZV assay for simultaneous detection and differentiation of three herpesviruses in cutaneous and mucocutaneous lesions. J Clin Microbiol. 2014;52:3799–3801. [PMC free article] [PubMed] [Google Scholar] 465. Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol. 2006;7:13–29. [PubMed] [Google Scholar] 466. Bennett S, Carman WF, Gunson RN. The development of a multiplex real-time PCR for the detection of herpes simplex virus 1 and 2, varizella zoster virus, adenovirus and Chlamydia trachomatis from eye swabs. J Virol Methods. 2013;189:143–147. [PMC free article] [PubMed] [Google Scholar] 467. Tan TY, Zou H, Ong DC, Ker KJ, Chio MT, Teo RY, Koh MJ. Development and clinical validation of a multiplex real-time PCR assay for herpes simplex and varicella zoster virus. Diagn Mol Pathol. 2013;22:245–248. [PubMed] [Google Scholar] 468. Buelow DR, Bankowski MJ, Fofana D, Gu Z, Pounds S, Hayden RT. Comparison of two multiplexed PCR assays for the detection of HSV-1, HSV-2, and VZV with extracted and unextracted cutaneous and mucosal specimens. J Clin Virol. 2013;58:84–88. [PubMed] [Google Scholar] 469. Sakai K, Wakasugi S, Muchemwa FC, Ihn H. Quick detection of herpes viruses from skin vesicles and exudates without nucleic acid extraction using multiplex PCR. Biosci Trends. 2008;2:164–168. [PubMed] [Google Scholar] 470. Binkhamis K, Al-Siyabi T, Heinstein C, Hatchette TF, LeBlanc JJ. Molecular detection of varicella zoster virus while keeping an eye on the budget. J Virol Methods. 2014;202:24–27. [PubMed] [Google Scholar] 471. Legoff J, Feghoul L, Mercier-Delarue S, Dalle JH, Scieux C, Chérot J, de Fontbrune FS, Baruchel A, Socié G, Simon F. Broad-range PCR-electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients. J Clin Microbiol. 2013;51:4186–4192. [PMC free article] [PubMed] [Google Scholar] 472. Lévêque N, Legoff J, Mengelle C, Mercier-Delarue S, N’guyen Y, Renois F, Tissier F, Simon F, Izopet J, Andréoletti L. Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples. J Clin Microbiol. 2014;52:212–217. [PMC free article] [PubMed] [Google Scholar] 473. Mehta SK, Tyring SK, Gilden DH, Cohrs RJ, Leal MJ, Castro VA, Feiveson AH, Ott CM, Pierson DL. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis. 2008;197:654–657. [PMC free article] [PubMed] [Google Scholar] 474. Leung J, Harpaz R, Baughman AL, Heath K, Loparev V, Vázquez M, Watson BM, Schmid DS. Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis. 2010;51:23–32. [PubMed] [Google Scholar] 475. Beards G, Graham C, Pillay D. Investigation of vesicular rashes for HSV and VZV by PCR. J Med Virol. 1998;54:155–157. [PubMed] [Google Scholar] 476. Nahass GT, Mandel MJ, Cook S, Fan W, Leonardi CL. Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction. J Am Acad Dermatol. 1995;32:730–733. [PubMed] [Google Scholar] 477. Vázquez M. Varicella infections and varicella vaccine in the 21st century. Pediatr Infect Dis J. 2004;23:871–872. [PubMed] [Google Scholar] 478. American Academy of Pediatrics. Varicella-Zoster Infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006: 711-725. Available from: https://redbook.solutions.aap.org/DocumentLibrary/2006 RB.pdf. [Google Scholar] 479. Shiraki K, Okuno T, Yamanishi K, Takahashi M. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV) J Gen Virol. 1982;61(Pt 2):255–269. [PubMed] [Google Scholar] 480. Oladepo DK, Klapper PE, Percival D, Vallely PJ. Serological diagnosis of varicella-zoster virus in sera with antibody-capture enzyme-linked immunosorbent assay of IgM. J Virol Methods. 2000;84:169–173. [PubMed] [Google Scholar] 481. Watson B, Keller PM, Ellis RW, Starr SE. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J Infect Dis. 1990;162:794–799. [PubMed] [Google Scholar] 482. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007;68:1069–1073. [PubMed] [Google Scholar] 483. Grahn A, Studahl M, Nilsson S, Thomsson E, Bäckström M, Bergström T. Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1. Clin Vaccine Immunol. 2011;18:1336–1342. [PMC free article] [PubMed] [Google Scholar] 484. Kangro HO, Manzoor S, Harper DR. Antibody avidity following varicella-zoster virus infections. J Med Virol. 1991;33:100–105. [PubMed] [Google Scholar] 485. Schoub BD, Blackburn NK, Johnson S, McAnerney JM, Miller B. Low antibody avidity in elderly chickenpox patients. J Med Virol. 1992;37:113–115. [PubMed] [Google Scholar] 486. Thomas HI, Morgan-Capner P, Meurisse EV. Studies on the avidity of IgG1 subclass antibody specific for varicella-zoster virus. Serodiagn immunother Infect Dis. 1990;4:371–377. [Google Scholar] 487. Kneitz RH, Schubert J, Tollmann F, Zens W, Hedman K, Weissbrich B. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis. 2004;4:33. [PMC free article] [PubMed] [Google Scholar] 488. L’Huillier AG, Ferry T, Courvoisier DS, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Hirschel B, Sottas C, et al. Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*. HIV Med. 2012;13:54–61. [PubMed] [Google Scholar] 489. Prelog M, Schönlaub J, Jeller V, Almanzar G, Höfner K, Gruber S, Eiwegger T, Würzner R. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients. Vaccine. 2013;31:2420–2426. [PubMed] [Google Scholar] 490. Ridings J, Nicholson IC, Goldsworthy W, Haslam R, Roberton DM, Zola H. Somatic hypermutation of immunoglobulin genes in human neonates. Clin Exp Immunol. 1997;108:366–374. [PMC free article] [PubMed] [Google Scholar] 491. Ridings J, Dinan L, Williams R, Roberton D, Zola H. Somatic mutation of immunoglobulin V(H)6 genes in human infants. Clin Exp Immunol. 1998;114:33–39. [PMC free article] [PubMed] [Google Scholar] 492. Junker AK, Tilley P. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox. J Med Virol. 1994;43:119–124. [PubMed] [Google Scholar] 493. Pretorius DH, Hayward I, Jones KL, Stamm E. Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med. 1992;11:459–463. [PubMed] [Google Scholar] 494. Scharf A, Scherr O, Enders G, Helftenbein E. Virus detection in the fetal tissue of a premature delivery with a congenital varicella syndrome. A case report. J Perinat Med. 1990;18:317–322. [PubMed] [Google Scholar] 495. Bruder E, Ersch J, Hebisch G, Ehrbar T, Klimkait T, Stallmach T. Fetal varicella syndrome: disruption of neural development and persistent inflammation of non-neural tissues. Virchows Arch. 2000;437:440–444. [PubMed] [Google Scholar] 496. Petignat P, Vial Y, Laurini R, Hohlfeld P. Fetal varicella-herpes zoster syndrome in early pregnancy: ultrasonographic and morphological correlation. Prenat Diagn. 2001;21:121–124. [PubMed] [Google Scholar] 497. Verstraelen H, Vanzieleghem B, Defoort P, Vanhaesebrouck P, Temmerman M. Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings. Prenat Diagn. 2003;23:705–709. [PubMed] [Google Scholar] 498. Mirlesse V, Solé Y, Jacquemard F, Delhommeau F, Daffos F. Persistent maternal viremia after varicella infection during pregnancy as a possible cause of false positive prenatal diagnosis of fetal infection on amniotic fluid. BJOG. 2004;111:885–887. [PubMed] [Google Scholar] 499. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2008;198:380.e1–380.e7. [PubMed] [Google Scholar] 500. Lécuru F, Taurelle R, Bernard JP, Parrat S, Lafay-pillet MC, Rozenberg F, Lebon P, Dommergues M. Varicella zoster virus infection during pregnancy: the limits of prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol. 1994;56:67–68. [PubMed] [Google Scholar] 501. Weisz B, Book M, Lipitz S, Katorza E, Achiron R, Grossman Z, Shrim A. Fetal outcome and amniocentesis results in pregnancies complicated by varicella infection. J Obstet Gynaecol Can. 2011;33:720–724. [PubMed] [Google Scholar] 502. Johansson AB, Rassart A, Blum D, Van Beers D, Liesnard C. Lower-limb hypoplasia due to intrauterine infection with herpes simplex virus type 2: possible confusion with intrauterine varicella-zoster syndrome. Clin Infect Dis. 2004;38:e57–e62. [PubMed] [Google Scholar] 503. Koskimies O, Lapinleimu K, Saxén L. Infections and other maternal factors as risk indicators for congenital malformations: a case-control study with paired serum samples. Pediatrics. 1978;61:832–837. [PubMed] [Google Scholar] 504. Sauerbrei A, Glück B, Jung K, Bittrich H, Wutzler P. Congenital skin lesions caused by intrauterine infection with coxsackievirus B3. Infection. 2000;28:326–328. [PubMed] [Google Scholar] 505. Sanchez MA, Bello-Munoz JC, Cebrecos I, Sanz TH, Martinez JS, Moratonas EC, Roura LC. The prevalence of congenital varicella syndrome after a maternal infection, but before 20 weeks of pregnancy: a prospective cohort study. J Matern Fetal Neonatal Med. 2011;24:341–347. [PubMed] [Google Scholar] 506. Kustermann A, Zoppini C, Tassis B, Della Morte M, Colucci G, Nicolini U. Prenatal diagnosis of congenital varicella infection. Prenat Diagn. 1996;16:71–74. [PubMed] [Google Scholar] 507. Isada NB, Paar DP, Johnson MP, Evans MI, Holzgreve W, Qureshi F, Straus SE. In utero diagnosis of congenital varicella zoster virus infection by chorionic villus sampling and polymerase chain reaction. Am J Obstet Gynecol. 1991;165:1727–1730. [PubMed] [Google Scholar] 508. Cuthbertson G, Weiner CP, Giller RH, Grose C. Prenatal diagnosis of second-trimester congenital varicella syndrome by virus-specific immunoglobulin M. J Pediatr. 1987;111:592–595. [PubMed] [Google Scholar] 509. Liesnard C, Donner C, Brancart F, Rodesch F. Varicella in pregnancy. Lancet. 1994;344:950–951. [PubMed] [Google Scholar] 510. Katz G, Pfau A. Congenital varicella causing neurogenic bladder and anal dysfunction. Urology. 1986;28:424–425. [PubMed] [Google Scholar] 511. Gershon AA. Varicella-zoster virus. In: Feign RD, Cherry JD. Tex-book of pediatric infectious diseases. Philadelphia: WB Saunders Company, 1998: 1769-1777 In: Feign RD, Cherry JD, editors. [Google Scholar] 512. Sauerbrei A, Müller D, Eichhorn U, Wutzler P. Detection of varicella-zoster virus in congenital varicella syndrome: a case report. Obstet Gynecol. 1996;88:687–689. [PubMed] [Google Scholar] 513. Al-Katawee YA, Al-Hasoun YA, Taha MN, Al-Moslem K. Congenital varicella-zoster virus infection. A rare case of severe brain and ocular malformations without limb or cutaneous involvement in a newborn after maternal subclinical infection. Saudi Med J. 2005;26:869–871. [PubMed] [Google Scholar] 514. Spranger S, Stute H, Blankenagel A, Jauch A, Hager D, Tariverdian G. MIDAS-Syndrom-Eine X-chromosomale Erkrankung. Differenzialdiagnose zum Kongenitalen Varizellensyndrom. Monatsschr Kinderheilkd. 1998;146:761–765. [Google Scholar] 515. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health. 1992;23:22–25. [PubMed] [Google Scholar] Which test is not suitable to diagnose shingles if clinical presentation is questionable?Polymerase Chain Reaction (PCR)
Other diagnostic methods, such as direct fluorescent antibody (DFA) or Tzanck smear testing, are not recommended because they aren't as sensitive as PCR.
Which of the following antibiotics may increase the likelihood of photosensitivity?What medications can cause photosensitivity? These common medications can make you more sensitive to the sun: Antibiotics, particularly tetracyclines like doxycycline and fluoroquinolones like ciprofloxacin. Tricyclic antidepressants like amitriptyline and nortriptyline.
|
Which test is not suitable to diagnose shingles of the clinical presentation is questionable?
zusammenhängende Posts
Urheberrechte © © 2024 ihoctot Inc.
